Tirzepatide: dosing chart, cost, and brand-name vs compounded
Zepbound® and Mounjaro® both contain tirzepatide, and some pharmacies compound it. See the doses, the prices and how the three differ, then have a licensed Zealthy provider review you online.
- FDA-approved tirzepatide, 5 to 15 mg: 15.0% to 20.9% average weight loss over 72 weeks in SURMOUNT-1, against 3.1% on placebo1
- When your plan covers Zepbound or Mounjaro, the copay can be as low as $25/mo*
- Compounded tirzepatide: $329/mo, or from $216/mo on a 3-month supply, shipping included†
- Online review by licensed providers for eligible adults in all 50 states
Tirzepatide has a boxed warning about thyroid tumors. See the important safety information.
What is tirzepatide?
It is a weekly prescription injection from Eli Lilly. One molecule switches on two receptors, one for the hormone GIP and one for GLP-1, so appetite drops and the stomach empties more slowly.2 How it works.
Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Eli Lilly makes Zepbound and Mounjaro, and the FDA approved both. Compounded tirzepatide is prepared by a pharmacy for one patient. It is not FDA-approved and not a generic, and the FDA does not review its safety, effectiveness or quality.3,4 Compare them.
What is the tirzepatide dosing schedule?
Zepbound begins at 2.5 mg weekly, moves to 5 mg after four weeks, and can then rise 2.5 mg at a time to 15 mg.2 On Zealthy’s 10 mg/mL compounded vial, 2.5 mg is 25 units. Follow the dose and units on your own prescription label. Full dosing chart.
*Needs a commercial plan that covers your prescribed brand, plus Eli Lilly’s savings card for it. Savings are capped, the cards expire December 31, 2026, and government coverage such as Medicare, Medicaid, TRICARE or VA rules them out.5,6 Insurance coordination requires an active Zealthy membership, and approval is never guaranteed. †$329 billed monthly, or from $216 a month on a 3-month supply. Compounded tirzepatide is not FDA-approved. The FDA does not review it for safety, effectiveness or quality. Prescribed only when a provider finds it appropriate. Membership ($39 in month one, then $135 monthly) is separate.
Safety summary: Tirzepatide’s label has a boxed warning for thyroid C-cell tumors. People who have had medullary thyroid carcinoma (MTC), or have a relative who has, and people with a condition called MEN 2 must not use it. Full safety information.
Tirzepatide led to 20.2% average weight loss in a 72-week trial against semaglutide
The number is from SURMOUNT-5, which enrolled 751 adults who had obesity but not type 2 diabetes. For 72 weeks they took FDA-approved tirzepatide, the medicine in Zepbound, at the highest dose they tolerated (10 mg or 15 mg a week), or semaglutide at 1.7 mg or 2.4 mg. Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide.7
The trial was open-label with no placebo group, and Eli Lilly paid for it. Results vary, and these are not results for compounded tirzepatide.
Arithmetic on one trial’s average, not a forecast of your own loss. No trial cited here tested compounded tirzepatide.
What each tirzepatide weight loss trial found
| Trial | Who took part | Weekly dose and length | Average weight change | Comparison group |
|---|---|---|---|---|
| SURMOUNT-11 | 2,539 adults with obesity or overweight, no diabetes | 5, 10 or 15 mg, 72 weeks | 15.0%, 19.5% and 20.9% lost | Placebo: 3.1% lost |
| SURMOUNT-28 | 938 adults with type 2 diabetes | 10 or 15 mg, 72 weeks | 12.8% and 14.7% lost | Placebo: 3.2% lost |
| SURMOUNT-49 | 670 adults after 36 weeks on tirzepatide | 10 or 15 mg, 52 more weeks | A further 5.5% lost | Moved to placebo: 14.0% regained |
| SURMOUNT-57 | 751 adults with obesity, no diabetes | 10 or 15 mg, 72 weeks | 20.2% lost | Semaglutide: 13.7% lost |
All four tested Eli Lilly’s FDA-approved tirzepatide, with Lilly funding.
What is tirzepatide, and which products contain it?
Tirzepatide is one active ingredient. Eli Lilly sells it as two brands with different FDA-approved uses. Compounded tirzepatide is a third category. It is not FDA-approved, and the FDA does not review its safety, effectiveness or quality.
| Feature | ZepboundThe weight brand | MounjaroThe diabetes brand |
|---|---|---|
| Ingredient | Tirzepatide | Tirzepatide |
| Approved uses | Weight loss and maintenance in adults with obesity, or with overweight plus a weight-related condition. Moderate to severe obstructive sleep apnea in adults who have obesity.2 | Blood sugar control in type 2 diabetes from age 10. Lower risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes at high risk.10 |
| Weight loss alone | On-label | Off-label. Mounjaro has no weight loss approval. |
| Strengths | 2.5, 5, 7.5, 10, 12.5 and 15 mg, injected weekly. | |
How tirzepatide works
One tirzepatide molecule binds to and activates two receptors, GIP and GLP-1. GLP-1 helps regulate appetite and food intake, and laboratory studies suggest GIP adds to that, so people eat fewer calories.2
The drug also slows stomach emptying, mostly after the first dose, and prompts insulin release when blood sugar is high. Its half-life is about five days, which is why one injection lasts a week.2 Our GLP-1 meaning guide explains the class.
In short
- Zepbound is approved for weight. Mounjaro is approved for type 2 diabetes, so taking it only to lose weight is off-label.
- Injection only. No tirzepatide tablet exists.2
- No generic either. As of November 2026, the FDA’s approved-drug database lists tirzepatide only under Eli Lilly’s two applications.11
How to get tirzepatide online through Zealthy
Every form of tirzepatide needs a prescription. Zealthy does the review online for eligible adults in all 50 states.
1. Tell us about your health
Sign up and fill in the intake: conditions, medications, weight history and goals. Membership is $39 for month one.

2. A licensed provider reads your intake
A U.S.-licensed physician or nurse practitioner decides whether tirzepatide is appropriate for you. No live appointment is needed to start, and video or phone visits are included if you want one.

3. We work with your insurance on Zepbound or Mounjaro
For a brand-name prescription, our insurance coordination team submits the prior authorization. If your plan covers it, the copay can be as low as $25 a month. Your plan decides, so approval is never certain.

4. Your prescription is filled
Brand-name prescriptions go to your own pharmacy. Compounded tirzepatide, if prescribed, ships from a partner pharmacy with supplies included, usually after 2 to 7 business days of processing.

5. Your dose is adjusted as you go
Message your care team with any question and work with your weight loss coach. Your provider decides when to raise, hold or lower the dose.


The same Zealthy membership for every form of tirzepatide
- Review by a licensed provider, and a prescription when appropriate
- An insurance coordination team for Zepbound and Mounjaro prior authorizations
- Unlimited secure messaging with your care team
- Optional monthly video or phone visits with a provider
- A weight loss coach, plus the Zealthy app and online portal
$39 in month one, then $135 monthly. Medication is a separate cost.
Tirzepatide side effects: how common each one is
Stomach and bowel symptoms lead the list. In Zepbound’s weight trials, 56% of adults at every dose reported at least one, against 30% on placebo.2
| Zepbound dose | 5 mg | 10 mg | 15 mg | Placebo |
|---|---|---|---|---|
| Nausea | 25% | 29% | 28% | 8% |
| Diarrhea | 19% | 21% | 23% | 8% |
| Constipation | 17% | 14% | 11% | 5% |
| Vomiting | 8% | 11% | 13% | 2% |
| Stomach pain | 9% | 9% | 10% | 5% |
| Indigestion | 9% | 9% | 10% | 4% |
| Injection site reactions | 6% | 8% | 8% | 2% |
| Hair loss | 5% | 4% | 5% | 1% |
Share of adults in Zepbound’s two main weight trials.2 Mounjaro’s diabetes trials showed lower rates, such as nausea in 12% to 18% against 4% on placebo.10 No trial measured compounded tirzepatide.
When do tirzepatide side effects happen?
Mostly while the dose is going up. Nausea, vomiting and diarrhea clustered around dose increases in the trials and became less common with time. Side effects led 4.8% to 6.7% of people on Zepbound to stop, against 3.4% on placebo.2
Hair loss and the new eye warning
Hair loss on Zepbound was tied to losing weight. It affected 7.1% of women and 0.5% of men.2
On November 9, 2026 the FDA said every GLP-1 label, Zepbound and Mounjaro included, must add a warning about a possible increased risk of NAION, a rare cause of sudden, painless vision loss in one eye.12 See our GLP-1 side effects guide.
Ways to ease side effects
- Tell your provider early. The label allows a longer stay on one dose, or a step back down.2
- Keep drinking fluids through any vomiting or diarrhea. Most kidney problems reported with tirzepatide followed dehydration.2
- Change the injection spot every week.2
Get medical help right away for
- Severe stomach pain that will not ease, sometimes reaching the back (possible pancreatitis).
- Upper stomach pain with fever, yellow skin or eyes, or clay-colored stools (gallbladder).
- Trouble breathing or swallowing, a swollen face, lips, tongue or throat, or a severe rash.
- Sudden vision loss in one eye.
- A lump in the neck or lasting hoarseness. See the boxed warning.12,13
Tirzepatide dosing chart: 2.5 mg to 15 mg
You inject tirzepatide once a week. Zepbound begins at 2.5 mg, and each 2.5 mg increase comes after four weeks or more on the current dose. This chart is the fastest schedule its label allows.2
| When | Weekly dose | What it is for |
|---|---|---|
| Weeks 1 to 4 | 2.5 mg | Starting dose. Not an approved long-term dose on Zepbound. |
| Weeks 5 to 8 | 5 mg | Required next step. Lowest maintenance dose for weight. |
| Weeks 9 to 12 | 7.5 mg | Optional step toward 10 mg. |
| Weeks 13 to 16 | 10 mg | Maintenance dose for weight or sleep apnea. |
| Weeks 17 to 20 | 12.5 mg | Optional step toward 15 mg. |
| Week 21 onward | 15 mg | Maintenance dose, and the maximum for every use. |
- 2.5 mgWeeks 1 to 4
- 5 mgWeeks 5 to 8
- 7.5 mgIf needed
- 10 mgIf needed
- 12.5 mgIf needed
- 15 mgMaximum
Your provider may keep you on a dose longer or settle below 15 mg. Mounjaro’s label raises the dose only when more blood sugar control is needed.10 Body weight, kidney disease and liver disease do not change the dose.2
Tirzepatide dose in units for Zealthy’s 10 mg/mL vial
Zealthy’s compounded tirzepatide ships in a 2 mL vial at 10 mg/mL (20 mg in the vial), with vitamin B12 (cyanocobalamin) at 500 mcg/mL. A U-100 insulin syringe holds 1 mL marked as 100 units, so here every 10 units is 1 mg.14
units = dose in mg ÷ mg per mL × 100
| Dose | Volume | Units on a U-100 syringe |
|---|---|---|
| 2.5 mg | 0.25 mL | 25 units |
| 5 mg | 0.5 mL | 50 units |
| 7.5 mg | 0.75 mL | 75 units |
| 10 mg | 1 mL | 100 units |
| 12.5 mg | 1.25 mL | 125 units |
| 15 mg | 1.5 mL | 150 units |
This chart fits a 10 mg/mL vial only. Units measure volume, not strength, so the same units give a different dose at another concentration.14 Above 10 mg, the dose is more than one 100-unit syringe holds, so ask your care team how to measure it. Always follow the dose and units on your own prescription label. Other concentrations: tirzepatide dosing in units.
If you miss a dose
- Within 4 days (96 hours) of the missed dose, take it as soon as you can.
- Past 4 days, skip it and wait for your usual day.
- Your injection day can move if the two doses are at least 3 days (72 hours) apart.2
How to take tirzepatide
- Pick one day a week. Time of day and meals do not matter.
- Inject under the skin of the stomach area or thigh. The upper arm is for when someone else injects.
- Took too much? Call Poison Help, 1-800-222-1222, right away.2,13
Semaglutide vs tirzepatide: the differences that matter
Both are weekly injections for weight and type 2 diabetes. Semaglutide works through one hormone receptor and tirzepatide through two. In the one large weight trial comparing them, tirzepatide led to more loss.7
| Feature | TirzepatideEli Lilly | SemaglutideNovo Nordisk |
|---|---|---|
| Receptors | GIP and GLP-1 | GLP-1 only |
| Approved uses | Zepbound: weight, obstructive sleep apnea. Mounjaro: type 2 diabetes, with heart risk in diabetes.2,10 | Wegovy®: weight, heart risk with cardiovascular disease, the liver disease MASH. Ozempic®: type 2 diabetes.15,16 |
| Weight loss in the same trial | 20.2% at 72 weeks7 | 13.7% at 72 weeks7 |
| Weight loss in separate placebo trials | 15.0% to 20.9% at 72 weeks. Placebo 3.1%.1 | 14.9% at 68 weeks on 2.4 mg. Placebo 2.4%.17 |
| Weekly injection dose | 2.5 to 15 mg | 0.25 to 7.2 mg (Wegovy), up to 2 mg (Ozempic)15,16 |
| Nausea in weight trials | 25% to 29%. Placebo 8%.2 | 44% on Wegovy 2.4 mg. Placebo 16%.15 |
| Tablet form | None | Yes, taken daily |
| Compounded price at Zealthy | $329/mo, or from $216/mo on a 3-month supply | $199/mo, or from $106/mo with a 3-month supply |
Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. Numbers from separate trials are not a like-for-like comparison. See also our semaglutide page.
What the head-to-head trials found
In SURMOUNT-5, 751 adults who had obesity but not type 2 diabetes took the highest dose they tolerated for 72 weeks. Weight fell 20.2% on tirzepatide and 13.7% on semaglutide, and waistlines shrank 18.4 cm and 13.0 cm. Stomach and bowel symptoms were the most common side effects in both groups.7
SURPASS-2 ran 40 weeks in 1,879 adults with type 2 diabetes. Weight fell 7.6 to 11.2 kg on tirzepatide and 5.7 kg on semaglutide 1 mg.10,18 See Mounjaro vs Ozempic.
Reasons to lean toward tirzepatide
- You want the larger average weight loss seen in trials.
- You have obesity with moderate to severe obstructive sleep apnea. Zepbound is approved for it.
How much does tirzepatide cost?
Tirzepatide costs anywhere from $25 a month with covered insurance to a list price above $1,000. The routes below are ordered by starting price.
| Route | Price per month | Details |
|---|---|---|
| Zepbound or Mounjaro on a commercial plan that covers it, plus Lilly’s card | As low as $25 | Savings are capped. Mounjaro’s card is for on-label use only.5,6 |
| Medicare GLP-1 Bridge | $50 | Zepbound KwikPen only, for eligible Part D members, July 1, 2026 through December 31, 2027.19 |
| Compounded tirzepatide at Zealthy | From $216 on a 3-month supply, or $329 billed monthly | Shipping included. Not FDA-approved. |
| Zepbound from Lilly, 2.5 mg or 5 mg | $299 or $399 | KwikPen or single-dose vials.20 |
| Zepbound from Lilly, 7.5 mg and higher | $449 | Only if each refill is bought within 45 days. Otherwise $499 for 7.5 mg and $699 above that.20 |
| Mounjaro from Lilly | From $499 | Single-dose pen, any strength.21 |
| List price, no discount | $499 to $1,086.37 Zepbound $1,112.16 Mounjaro | Lilly’s published price per fill.22,23 |
Each Lilly card and self-pay offer we checked expires December 31, 2026. Zealthy prices cover medication only, not membership.
Tirzepatide cost with insurance
A covered brand-name prescription can cost $25 for a one-, two- or three-month fill with Lilly’s savings card.5,6 Coverage is the hard part. In KFF’s 2026 employer survey, 18% of firms with 200 or more workers covered GLP-1 medications for weight loss, while plans have generally covered them for diabetes.24
Zealthy’s insurance coordination team submits prior authorizations for brand-name medication. You need an active membership, and your plan decides. Try our GLP-1 insurance checker.
Tirzepatide cost without insurance
Without insurance, the FDA-approved route is Zepbound at Lilly’s self-pay prices in the table. A month is one KwikPen or four single-dose vials, and needles or syringes cost extra.20 Whatever you price, add the visit or membership fee that comes with the prescription.
Lilly savings cards and LillyDirect
No coupon exists for tirzepatide itself. Each brand has its own card. Zepbound’s takes up to $100 off a one-month fill of the single-dose pen, to a yearly limit of $1,300. Mounjaro’s takes up to $150 off a month, to $1,950 a year.5,6 Nobody covered by Medicare, Medicaid, TRICARE, VA or another government program can use them.
LillyDirect is Lilly’s own pharmacy channel. It does not write prescriptions, so a licensed provider has to send one.20 See our Zepbound and Mounjaro pages.
What tirzepatide costs through Zealthy
- Membership: $39 in month one, then $135 monthly. Medication is extra.
- Zepbound or Mounjaro: filled at your own pharmacy. With plan coverage the copay can be as low as $25 a month.
- Compounded tirzepatide: $329 a month, or from $216 a month on a 3-month supply, shipping included.
- Bundle: membership and compounded tirzepatide together, $349 for the first month, then $449 a month.
Compounded tirzepatide is not FDA-approved. The FDA does not review it for safety, effectiveness or quality. A Zealthy provider prescribes it only when it is appropriate for you.
Cheap tirzepatide offers the FDA warns about
- Vials sold “for research purposes” or “not for human consumption”, whose quality is unknown.
- Sellers that skip the screening and prescription from a licensed prescriber.
- Labels with spelling errors or a pharmacy you cannot verify. The FDA has seen fraudulent compounded tirzepatide with false label information.3
Buy only with a prescription, from a state-licensed pharmacy. Our tirzepatide near me guide compares the options.
Compounded tirzepatide vs brand-name: where the FDA stands
A pharmacy prepares compounded tirzepatide for one person’s prescription. It is not Zepbound, Mounjaro or a generic. It is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.3,4
| Feature | Zepbound or MounjaroBrand-name | Compounded tirzepatideThrough Zealthy |
|---|---|---|
| Who makes it | Eli Lilly | A partner pharmacy, for an individual prescription |
| FDA-approved | Yes | No |
| FDA review of safety, effectiveness and quality | Yes, before approval | None before it is sold |
| Studied in the trials on this page | Yes | No |
| What you receive | A pen or vial at one of six set strengths | A 2 mL vial at 10 mg/mL (20 mg in the vial), with vitamin B12 (cyanocobalamin) at 500 mcg/mL |
| Measuring a dose | Each pen or vial delivers a set volume | Drawn into a syringe, in the units on your label |
Can pharmacies still compound tirzepatide?
Only in limited circumstances. The FDA declared the tirzepatide shortage resolved in late 2024, and the grace periods it gave compounders ended in March 2025.25
On April 1, 2026, the FDA said tirzepatide is on neither its shortage list nor its list of bulk substances that outsourcing facilities may compound from. State-licensed pharmacies may not make, regularly or in large amounts, what are essentially copies of a commercially available drug, unless a prescriber determines that a change makes a significant difference for an identified patient.25
The FDA added that it may treat a compound pairing a GLP-1 ingredient with another, such as vitamin B12, as essentially a copy when it is given the same way at a strength within 10% of the commercial product. Its example was semaglutide.25 Zealthy’s compounded tirzepatide contains vitamin B12. The FDA’s position is that compounded drugs should be used only when an approved drug cannot meet a patient’s medical need.3
Risks the FDA has flagged
- More than 730 adverse event reports tied to compounded tirzepatide by May 31, 2026, likely an undercount.
- Doses larger, more frequent or raised faster than approved labels allow.
- Vials that arrive warm, or are kept more than 28 days after first use.3
- Measuring mistakes. With compounded semaglutide vials, people drew up 5 to 20 times the intended dose.14
How it works at Zealthy
- Whether compounded tirzepatide suits you is a licensed provider’s decision.
- Message your care team before injecting if anything on your label is unclear.
Tirzepatide brands next to semaglutide brands
Zealthy providers can prescribe four brand-name GLP-1 medications. Two contain tirzepatide and two contain semaglutide.
| Feature | Zepbound | Mounjaro | Wegovy | Ozempic |
|---|---|---|---|---|
| Ingredient | Tirzepatide | Tirzepatide | Semaglutide | Semaglutide |
| Approved uses | Weight, sleep apnea | Type 2 diabetes | Weight, heart risk, MASH | Type 2 diabetes |
| Weight loss use | On-label | Off-label | On-label | Off-label |
| Highest weekly dose | 15 mg | 15 mg | 7.2 mg | 2 mg |
| Compounded option at Zealthy | Compounded tirzepatide, $329/mo or from $216/mo | Compounded semaglutide, $199/mo or from $106/mo | ||
From each product’s prescribing information.2,10,15,16 Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality.
What members say about care at Zealthy
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.

A licensed provider decides if tirzepatide fits you, and in which form
U.S.-licensed physicians and nurse practitioners read your intake, check it against the warnings for tirzepatide, and prescribe Zepbound, Mounjaro or compounded tirzepatide only when one of them is appropriate. They also set the pace of every dose increase.
The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.
Tirzepatide questions and answers
What is tirzepatide used for?
Weight management, obstructive sleep apnea and type 2 diabetes, depending on the brand. Zepbound is approved for weight in adults who have obesity, or overweight with a weight-related condition, and for sleep apnea with obesity. Mounjaro is approved for type 2 diabetes.
Are tirzepatide, Zepbound and Mounjaro the same thing?
Tirzepatide is the ingredient, and Zepbound and Mounjaro are the two brand names Eli Lilly sells it under. Both come in the same six strengths and carry the same boxed warning. They differ in their FDA-approved uses, which usually decides what insurance pays for.
How much weight do people lose on tirzepatide?
In SURMOUNT-1, adults without diabetes lost an average of 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg over 72 weeks, compared with 3.1% on placebo. Both the trial and the figures belong to FDA-approved tirzepatide, and individual results vary.
What is the starting dose of tirzepatide?
The starting dose is 2.5 mg once a week. Zepbound keeps you there for four weeks and then moves to 5 mg, because 2.5 mg is not an approved long-term dose. Later increases are 2.5 mg each, up to 15 mg. See the dosing chart.
How many units is 2.5 mg of tirzepatide?
On a 10 mg/mL vial, such as Zealthy’s compounded tirzepatide, 2.5 mg is 25 units on a U-100 insulin syringe. Another concentration changes the number: at 20 mg/mL, 2.5 mg is 12.5 units. Check the units printed on your own prescription label before every dose.
Is tirzepatide better than semaglutide for weight loss?
On average it led to more weight loss. Adults with obesity in SURMOUNT-5 lost 20.2% on tirzepatide and 13.7% on semaglutide over 72 weeks. It is not better for everyone: semaglutide comes as a tablet and has a heart-risk approval that does not depend on diabetes.
How do you switch from semaglutide to tirzepatide?
With your provider, because no official dose conversion exists. Neither label gives one, and Eli Lilly says the recommended Zepbound starting dose is 2.5 mg. The two are not taken together, since Zepbound is not recommended with any GLP-1 medicine.
How much is tirzepatide without insurance?
As of November 2026, Zepbound through LillyDirect is $299 a month at 2.5 mg, then $399 at 5 mg, and $449 above that if refilled within 45 days. Compounded tirzepatide at Zealthy is $329 a month, or from $216 on a 3-month supply, and is not FDA-approved.
Does insurance or Medicare cover tirzepatide?
Sometimes. Plans have generally covered GLP-1 medications for diabetes, Mounjaro’s approved use. For weight, 18% of large employers covered them in KFF’s 2026 survey. Medicare’s GLP-1 Bridge offers the Zepbound KwikPen at $50 a month to eligible Part D members.
Is compounded tirzepatide FDA-approved?
No. The FDA does not approve compounded drugs or review them for safety, effectiveness or quality before they are sold. It says they should be used only when an approved drug cannot meet a patient’s medical need. Zealthy providers prescribe one only when they judge it appropriate.
Is there a generic tirzepatide?
No. As of November 2026, the FDA’s approved-drug database lists tirzepatide only under Eli Lilly’s applications for Mounjaro and Zepbound, so no generic has been approved. Compounded tirzepatide is sometimes called a generic, but the FDA says a compounded drug is not one.
Can I get tirzepatide online?
Yes. A licensed provider can review your health history online and send a prescription to a pharmacy. At Zealthy, a U.S.-licensed physician or nurse practitioner reads your intake, for eligible adults in all 50 states. The FDA warns against sellers that skip the prescription.
Is a video appointment required to start tirzepatide at Zealthy?
No. A licensed provider reviews your intake online, so starting does not require a live appointment. Video or phone visits with a provider are part of the membership if you want one. Membership is $39 in month one and then $135 monthly.
How long does compounded tirzepatide take to arrive?
Most Zealthy members receive it within 2 to 9 business days of the prescription. The partner pharmacy usually needs 2 to 7 business days to process the order, then ships with 2-day delivery. A 3-month supply usually comes as one shipment of three vials.
What are the most common side effects of tirzepatide?
Nausea and diarrhea are the most common, then constipation, vomiting, indigestion and stomach pain. About 25% to 29% of adults in Zepbound’s weight trials had nausea, against 8% on placebo. Most stomach symptoms came during dose increases and eased with time.
What happens when you stop taking tirzepatide?
Weight usually comes back. In SURMOUNT-4, adults who had taken tirzepatide for 36 weeks either stayed on it or moved to placebo for 52 more weeks. The placebo group regained 14.0% of their body weight, while the group that continued lost a further 5.5%.
Can I take tirzepatide while pregnant or on birth control pills?
Not for weight loss during pregnancy. Zepbound’s label says to stop once pregnancy is recognized, because weight loss then may harm the baby. Tirzepatide can also weaken birth control pills, so the label advises a non-oral or barrier method for 4 weeks after the first dose and each increase.
More tirzepatide guides and tools
Important safety information
This summary draws on the labels for Zepbound and Mounjaro.2,10 Compounded tirzepatide has not been reviewed by the FDA. Treat every warning here as applying to it too.
Boxed warning: thyroid C-cell tumor risk
Tirzepatide caused thyroid C-cell tumors in rats, and the risk rose with dose and length of treatment. Whether it causes these tumors, including medullary thyroid carcinoma (MTC), in people is unknown. Tirzepatide is not for anyone who has had MTC, anyone with a relative who has had it, or anyone with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report a neck lump, lasting hoarseness, shortness of breath or trouble swallowing to your provider.
Who should not take tirzepatide
- People who have had MTC or have MEN 2, and people with a relative who has had MTC.
- People with a past serious allergic reaction to tirzepatide, or to another ingredient in the product.
Tell your provider before you start if you
- have pancreas problems now, or had them in the past
- have severe stomach problems, such as slow stomach emptying (gastroparesis)
- have a history of diabetic retinopathy
- take insulin, a sulfonylurea or other diabetes medicines
- have surgery or a procedure with anesthesia or deep sedation coming up
- are pregnant, plan a pregnancy, or are breastfeeding
- take birth control pills, which tirzepatide can make less effective
- use another tirzepatide product or any GLP-1 medicine2,13
Possible serious side effects
- Severe stomach problems
- Kidney problems after fluid loss from nausea, vomiting or diarrhea
- Gallbladder problems
- Pancreatitis, an inflamed pancreas
- Serious allergic reactions
- Low blood sugar, mainly alongside insulin or a sulfonylurea
- Vision changes for people who have type 2 diabetes
- Stomach contents entering the lungs under anesthesia or deep sedation13
- NAION, a rare optic nerve condition causing sudden vision loss in one eye. The FDA required this warning on November 9, 2026, and the labels did not yet include it on November 18.12
Most common side effects
Zepbound: nausea, diarrhea, constipation, vomiting, indigestion, stomach pain, injection site reactions, tiredness, allergic reactions, belching, heartburn and hair loss. Mounjaro: the same stomach and bowel symptoms, plus decreased appetite.2,10
This summary is not complete and does not replace your provider’s advice. See the full Prescribing Information for Zepbound and Mounjaro. Report side effects to the FDA on 1-800-FDA-1088 or at www.fda.gov/medwatch. Reviewed by the Zealthy care team, November 18, 2026.
Sources
All accessed November 18, 2026.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Zepbound (tirzepatide) prescribing information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/zepbound-uspi.pdf
- U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Eli Lilly and Company. Zepbound savings options and Savings Card terms. https://zepbound.lilly.com/savings
- Eli Lilly and Company. Mounjaro savings and Savings Card terms. https://mounjaro.lilly.com/savings-resources
- Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
- Garvey WT, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. https://pubmed.ncbi.nlm.nih.gov/37385275/
- Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. https://pubmed.ncbi.nlm.nih.gov/38078870/
- Mounjaro (tirzepatide) prescribing information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
- U.S. Food and Drug Administration. Drugs@FDA records for tirzepatide, through openFDA. https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name:%22TIRZEPATIDE%22&limit=50
- U.S. Food and Drug Administration. Drug Safety Communication on GLP-1 receptor agonists and a rare eye condition (NAION). November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
- Zepbound (tirzepatide) Medication Guide. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/zepbound-us-mg.pdf
- U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
- Wegovy (semaglutide) prescribing information. Novo Nordisk. Revised 06/2026. https://www.novo-pi.com/wegovy.pdf
- Ozempic (semaglutide) prescribing information. Novo Nordisk. Revised 05/2026. https://www.novo-pi.com/ozempic.pdf
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Frías JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/
- Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/glp1bridge
- Eli Lilly and Company. Zepbound through LillyDirect. https://www.lilly.com/lillydirect/zepbound
- Eli Lilly and Company. Mounjaro through LillyDirect. https://www.lilly.com/lillydirect/medicines/mounjaro
- Eli Lilly and Company. Zepbound list price. https://pricinginfo.lilly.com/zepbound
- Eli Lilly and Company. Mounjaro list price. https://pricinginfo.lilly.com/mounjaro
- KFF. 2026 Employer Health Benefits Survey. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
- U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Updated April 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
Find out whether tirzepatide is an option for you
A U.S.-licensed provider reads your online intake and tells you which form of tirzepatide, if any, fits.
Get Started